ArticleBreast cancer research : BCR2015

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.

Mari Tinholt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.